As Europe's second largest biotechnology market, France offers a market depth that needs to be supported. This premise led Goodwin to recruit Anne-Charlotte Rivière as a partner in Paris in order to form a venture division dedicated to Life Sciences and Technologies. Read the announcement in CF News here.
Related Content
- AlertOctober 23, 2023
New California Law to Require Venture Capital Firms to Disclose Founder Diversity Information
- AlertJune 28, 2023
FTC and DOJ Propose Major Changes to HSR Form and Disclosure
- AlertJune 2, 2023
Current Issues for Qualified Small Business Stock — How New R&E Expensing Rules Could Hurt Your QSBS Status, and Why Cash Management Changes Likely Won’t
- AlertMarch 11, 2023
The Silicon Valley Bank UK insolvency: FAQ for those doing business with the Bank
- AlertMarch 3, 2023
Part III: What Primary Mitigation Strategies Exist for Companies with Double-Vest RSUs That May Be Expiring?
- AlertFebruary 23, 2023
Part II: Why Do Private Companies Shift From Stock Options to Double-Vest RSUs?
- AlertFebruary 16, 2023
Part I: What are “Double-Vest” RSUs and Why Are They Making Headlines?
- AlertJanuary 10, 2023
Deadline Approaching for Reporting 2022 ISO Exercises and ESPP Transfers
- Awards and RankingsNovember 16, 2023
JUVE 2023/2024 Recommends Goodwin Partners and Practices Across Germany
- Awards and RankingsOctober 19, 2023
Chambers UK 2024 Highly Ranks Goodwin Lawyers and Practices in London and Cambridge
- Press ReleaseOctober 10, 2023
TQ Ventures and Menlo Ventures Co-Lead Cleanlab’s $25 Million Series A Investment
- Press ReleaseOctober 5, 2023
Blackbird Labs Raises $24 Million Series A Round
- Awards and RankingsOctober 5, 2023
The Legal 500 UK 2024 Highly Ranks 25 Practices and 39 Lawyers Across London and Cambridge
- Press ReleaseOctober 3, 2023
Yotta Energy Secures $8 Million Funding Led by Evergy Ventures
- Press ReleaseSeptember 28, 2023
at.inc/ Invests in Digma’s $6 Million Seed Funding
- In the PressSeptember 28, 2023
FemHealth Ventures Closes $32 Million Fund for Women’s Health Investments (The Wall Street Journal)